Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-37.28	45.25	72.15
Graham Fair Price	10.77	73393.29	66257.68
PEG	329.98	-1.04	0.24
Price/Book	-12.91	0.35	0.40
Price/Cash Flow	59.33	-3.04	-7.48
Prices/Earnings	25.03	-20.23	-26.98
Price/Sales	-7.29	0.42	0.45
Price/FCF	59.33	-3.04	-7.48
Naive Interpretation	member

01 - Valuation · Somewhat Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	115.81	0.08	0.04
Operating Margin	286.22	0.03	< 0.005
ROA	-11.72	< 0.005	< 0.005
ROE	< 0.005	< 0.005	-16.16
ROIC	< 0.005	-0.06	-4902.52
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	0.10	< 0.005	1932.82
Dividends QOQ	-0.42	0.15	-64.77
EBIT QOQ	-1.11	4.73	327.11
EPS QOQ	-1.11	-0.19	82.56
FCF QOQ	0.37	-1.20	228.03
Revenue QOQ	-0.02	-0.03	-90.84
Naive Interpretation	member

03 - Financial Growth · Balanced

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	53.15	63.25	19.01
Days Sales Outstanding (DSO)	36.36	40.49	11.34
Inventory Turnover	1.69	1.42	-15.97
Debt/Capitalization	0.57	0.59	2.97
Quick Ratio	0.72	0.71	-2.32
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	230169.26	236557.57	2.78
Cash	138870.56	138405.65	-0.33
Capex	-37577.89	-16799.42	55.29
Free Cash Flow	-12238.69	-26932.34	-120.06
Revenue	202454.73	195465.89	-3.45
Naive Interpretation	member

05 - Per Share Metrics · Bad

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	1.13	1.15	1.46
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	47.92	32.61	-31.96
Naive Interpretation	Member

06 - Financial Health · Bad

Rating